261 related articles for article (PubMed ID: 24252331)
1. Metabolomic analyses for atherosclerosis, diabetes, and obesity.
Du F; Virtue A; Wang H; Yang XF
Biomark Res; 2013 Apr; 1(1):17. PubMed ID: 24252331
[TBL] [Abstract][Full Text] [Related]
2. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus.
Wang C; Yu J; Zhang R; Wang W; Shi Z; Liu Y; Song G; Wang H; Han N; Huang L; An Y; Tian S; Chen Z
J Proteomics; 2020 Jul; 223():103823. PubMed ID: 32428569
[TBL] [Abstract][Full Text] [Related]
3. Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus.
Gu X; Al Dubayee M; Alshahrani A; Masood A; Benabdelkamel H; Zahra M; Li L; Abdel Rahman AM; Aljada A
Front Mol Biosci; 2020; 7():609806. PubMed ID: 33381523
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
5. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer.
Matsuda M; Shimomura I
Obes Res Clin Pract; 2013; 7(5):e330-41. PubMed ID: 24455761
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes.
Abu Bakar MH; Sarmidi MR; Cheng KK; Ali Khan A; Suan CL; Zaman Huri H; Yaakob H
Mol Biosyst; 2015 Jul; 11(7):1742-74. PubMed ID: 25919044
[TBL] [Abstract][Full Text] [Related]
7. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes.
Al-Sulaiti H; Diboun I; Agha MV; Mohamed FFS; Atkin S; Dömling AS; Elrayess MA; Mazloum NA
J Transl Med; 2019 Oct; 17(1):348. PubMed ID: 31640727
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial reactive oxygen species and risk of atherosclerosis.
Hulsmans M; Van Dooren E; Holvoet P
Curr Atheroscler Rep; 2012 Jun; 14(3):264-76. PubMed ID: 22350585
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics-Based Prospective Studies and Prediction of Type 2 Diabetes Mellitus Risks.
Satheesh G; Ramachandran S; Jaleel A
Metab Syndr Relat Disord; 2020 Feb; 18(1):1-9. PubMed ID: 31634052
[TBL] [Abstract][Full Text] [Related]
10. Are we close to defining a metabolomic signature of human obesity? A systematic review of metabolomics studies.
Rangel-Huerta OD; Pastor-Villaescusa B; Gil A
Metabolomics; 2019 Jun; 15(6):93. PubMed ID: 31197497
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between Autophagy and Metabolic Syndrome Characteristics in the Pathogenesis of Atherosclerosis.
Xu J; Kitada M; Ogura Y; Koya D
Front Cell Dev Biol; 2021; 9():641852. PubMed ID: 33937238
[TBL] [Abstract][Full Text] [Related]
12. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
Wang N; Zhu F; Chen L; Chen K
Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
[TBL] [Abstract][Full Text] [Related]
13. Circulating PCSK9 in patients with type 2 diabetes and related metabolic disorders.
Ibarretxe D; Girona J; Plana N; Cabré A; Ferré R; Amigó N; Guaita S; Mallol R; Heras M; Masana L
Clin Investig Arterioscler; 2016; 28(2):71-8. PubMed ID: 26743379
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of Type 2 Diabetes Mellitus.
Galicia-Garcia U; Benito-Vicente A; Jebari S; Larrea-Sebal A; Siddiqi H; Uribe KB; Ostolaza H; Martín C
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872570
[TBL] [Abstract][Full Text] [Related]
15. Metabolites as regulators of insulin sensitivity and metabolism.
Yang Q; Vijayakumar A; Kahn BB
Nat Rev Mol Cell Biol; 2018 Oct; 19(10):654-672. PubMed ID: 30104701
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of diabetes and atherosclerosis: role of adiponectin.
Kishida K; Funahashi T; Shimomura I
Endocr Metab Immune Disord Drug Targets; 2012 Jun; 12(2):118-31. PubMed ID: 22236026
[TBL] [Abstract][Full Text] [Related]
17. Lipid Metabolite Biomarkers in Cardiovascular Disease: Discovery and Biomechanism Translation from Human Studies.
McGranaghan P; Kirwan JA; Garcia-Rivera MA; Pieske B; Edelmann F; Blaschke F; Appunni S; Saxena A; Rubens M; Veledar E; Trippel TD
Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564437
[TBL] [Abstract][Full Text] [Related]
18. Power of metabolomics in biomarker discovery and mining mechanisms of obesity.
Zhang A; Sun H; Wang X
Obes Rev; 2013 Apr; 14(4):344-9. PubMed ID: 23279162
[TBL] [Abstract][Full Text] [Related]
19. Type 2 Diabetes Mellitus Increases The Risk of Late-Onset Alzheimer's Disease: Ultrastructural Remodeling of the Neurovascular Unit and Diabetic Gliopathy.
Hayden MR
Brain Sci; 2019 Sep; 9(10):. PubMed ID: 31569571
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
